AMGEN

pharmaceutical preparations, namely, erythropoietin for use in treating chronic anemia, granulocyte colony stimulating factor and granuloctye-macrophage colony stimulating factor for use in restoring the level of white blood cells, [ hepatitis B vaccine, ] interferon and interleukin 2 for use in anticancer and antiviral applications, epidermal growth factor and platelet derived growth * factor * for use in treating surgical or soft tissue damage; [ and pharmaceutical preparations for animal health care, namely, bovine somatotropin for use in increasing milk yield in dairy cattle and porcine somatotropin for use in reducing the fat content of pork ]